INS and diabetes mellitus: R7.2a: Since treatment with ICPI using anti-PD-1 or PD-L1 can lead to presentation of fulminant symptoms of diabetes with major insulinopenia, we recommend urgently initiating insulin treatment via multiple injections as first line treatment, and patient management and diabetes education in a specialized service.